Methyl-vitamin B12 blocks the CD28 co-stimulatory pathway in human T cells and its possible therapeutic application for T cell-mediated diseases, including rheumatoid arthritis
Japanese Journal of Rheumatology · 1997
DOI: 10.1007/bf03041231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Rheumatology, 1997. Verfasst von Hiroko Nagafuchi und 3 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nagafuchi, H., Suzuki, N., Takeno, M., & Sakane, T. (1997). Methyl-vitamin B12 blocks the CD28 co-stimulatory pathway in human T cells and its possible therapeutic application for T cell-mediated diseases, including rheumatoid arthritis. Japanese Journal of Rheumatology. https://doi.org/10.1007/bf03041231
Vancouver
Nagafuchi H, Suzuki N, Takeno M, Sakane T. Methyl-vitamin B12 blocks the CD28 co-stimulatory pathway in human T cells and its possible therapeutic application for T cell-mediated diseases, including rheumatoid arthritis. Japanese Journal of Rheumatology. 1997. doi:10.1007/bf03041231
BibTeX
@article{Nagafuchi1997,
author = {Nagafuchi, Hiroko and Suzuki, Noboru and Takeno, Mitsuhiro and Sakane, Tsuyoshi},
title = {Methyl-vitamin B12 blocks the CD28 co-stimulatory pathway in human T cells and its possible therapeutic application for T cell-mediated diseases, including rheumatoid arthritis},
journal = {Japanese Journal of Rheumatology},
year = {1997},
doi = {10.1007/bf03041231}
}
EUVIMED